Literature DB >> 7684975

Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice.

A A Donjacour1, G R Cunha.   

Abstract

Urogenital sinus mesenchyme (UGM) from normal, androgen receptor-positive mice appears to instructively induce prostatic morphology in urinary tract epithelium from both normal and androgen-insensitive (Tfm) mice. This indicates that epithelial androgen receptors are not necessary for prostatic development. However, the secretory function of these tissue recombinants has never been assessed. In this study antisera to androgen-dependent dorsolateral prostate (DLP) secretion were used in immunocytochemistry, Western blotting, and immunoprecipitation techniques to detect the presence of these prostatic proteins in tissue recombinants made with either normal or Tfm epithelium. In a majority of cases, UGM plus normal bladder or urethral epithelium developed into prostatic tissue that produced androgen-dependent DLP proteins. Hence UGM appeared to be capable of instructively inducing a functional prostatic phenotype in these normal heterotypic epithelia. With rare exceptions, tissue recombinants of UGM plus Tfm bladder or urethral epithelium did not produce full prostatic cytodifferentiation or mouse DLP proteins, indicating that epithelial androgen receptors are important for the final stages of morphogenesis and in the initiation of secretory function in the prostate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684975     DOI: 10.1210/endo.132.6.7684975

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  49 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

Review 2.  Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants.

Authors:  G R Cunha; P Young; Y K Hom; P S Cooke; J A Taylor; D B Lubahn
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

3.  Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line.

Authors:  Aubie Shaw; John Papadopoulos; Curtis Johnson; Wade Bushman
Journal:  Prostate       Date:  2006-09-15       Impact factor: 4.104

Review 4.  Developmental estrogen exposures predispose to prostate carcinogenesis with aging.

Authors:  Gail S Prins; Lynn Birch; Wan-Yee Tang; Shuk-Mei Ho
Journal:  Reprod Toxicol       Date:  2006-10-24       Impact factor: 3.143

5.  Androgen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathways.

Authors:  Yongbing Pu; Liwei Huang; Lynn Birch; Gail S Prins
Journal:  Endocrinology       Date:  2007-01-11       Impact factor: 4.736

6.  Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

Authors:  Emily A Ricke; Karin Williams; Yi-Fen Lee; Suzana Couto; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; William A Ricke
Journal:  Carcinogenesis       Date:  2012-04-25       Impact factor: 4.944

Review 7.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

Review 8.  Molecular signaling pathways that regulate prostate gland development.

Authors:  Gail S Prins; Oliver Putz
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

Review 9.  Exploring the origins of the normal prostate and prostate cancer stem cell.

Authors:  Susan Kasper
Journal:  Stem Cell Rev       Date:  2008-09       Impact factor: 5.739

Review 10.  Mesenchymal-epithelial interaction techniques.

Authors:  Gerald R Cunha; Lawrence Baskin
Journal:  Differentiation       Date:  2015-11-21       Impact factor: 3.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.